Psychedelic Finance (@Psych_Fin) header
Psychedelic Finance (@Psych_Fin) profile picture

Psychedelic Finance

@Psych_Fin

Helping investors discover, understand, and stay up-to-date on opportunities within the Psychedelic industry. Inquiries: [email protected]

 Canada
psychedelicfinance.com
Joined November 2019
  • Tweets4.3K
  • Following153
  • Followers20.8K
45Media
Photo by Psychedelic Finance (@Psych_Fin)Photo by Psychedelic Finance (@Psych_Fin)Photo by Psychedelic Finance (@Psych_Fin)Photo by Psychedelic Finance (@Psych_Fin)Photo by Psychedelic Finance (@Psych_Fin)Photo by Psychedelic Finance (@Psych_Fin)Photo by Psychedelic Finance (@Psych_Fin)Photo by Psychedelic Finance (@Psych_Fin)
Psychedelic Finance retweeted
The Tape (@TheTape_TNM) profile picture
The Tape
@TheTape_TNMSep 8
Breaking: $DFTX receives FDA Breakthrough Therapy designation for DT120 in major depression after a positive Phase 3 trial showed durable improvement through Week 12.
1
1
7
1,101
Psychedelic Finance retweeted
The Tape (@TheTape_TNM) profile picture
The Tape
@TheTape_TNMAug 14
Breaking: $HELP completes enrollment in its Phase 3 HLP003 depression trial with topline data expected in Q4, while Q1 net loss widens to $47.8 million and cash stands at $166.4 million.
2
9
762
Psychedelic Finance retweeted
The New Money (@thenewmoney) profile picture
The New Money
@thenewmoneyAug 6
Breaking: Compass Pathways has partnered with the U.S. Department of Veterans Affairs for a new psilocybin study. $CMPS $ATAI $LLY thenew.money/article/compass…
Compass Pathways Launches New Psilocybin Study With U.S. Department of Veterans Affairs | The New...

Compass Pathways Launches New Psilocybin Study With U.S. Department of Veterans Affairs | The New...

Compass Pathways (NASDAQ: CMPS) has partnered with the United States Department of Veterans Affairs on a multi-site randomized controlled clinical trial.

thenew.money
3
6
781
Psychedelic Finance retweeted
The Tape (@TheTape_TNM) profile picture
The Tape
@TheTape_TNMAug 6
Breaking: $CMPS partners with the U.S. Department of Veterans Affairs on a five-site trial of COMP360 psilocybin for veterans with treatment-resistant depression, including those with PTSD.
2
4
13
830
Psychedelic Finance retweeted
The Tape (@TheTape_TNM) profile picture
The Tape
@TheTape_TNMAug 4
Breaking: Shares of psychedelic drug discovery company $HELP have surged +50% over the past month.
Image from The Tape (@TheTape_TNM)
2
3
11
789
Psychedelic Finance retweeted
The Tape (@TheTape_TNM) profile picture
The Tape
@TheTape_TNMJul 21
Breaking: $HELP completes 223-patient Phase 3 enrollment for depression drug HLP003 ahead of schedule, with topline data due Q4 2026.
1
2
12
567
Psychedelic Finance retweeted
The New Money (@thenewmoney) profile picture
The New Money
@thenewmoneyJul 16
Eli Lilly has entered into a new deal to acquire AtaiBeckley for up to $3.5 billion in the drugmaker’s first ever psychedelic drug discovery acquisition. $ATAI $LLY @C_Angermayer thenew.money/article/eli-lil…
Eli Lilly Is Acquiring AtaiBeckley For Psychedelic Drug Development | The New Money

Eli Lilly Is Acquiring AtaiBeckley For Psychedelic Drug Development | The New Money

Eli Lilly (NYSE: LLY) has entered into a new deal to acquire AtaiBeckley (NASDAQ: ATAI) for up to $3.5 billion.

thenew.money
5
8
947
Psychedelic Finance retweeted
The New Money (@thenewmoney) profile picture
The New Money
@thenewmoneyJun 26
Definium Therapeutics has just completed a massive new capital raise. And they are aiming to use it to bring their most advanced psychedelic derived drug into commercialization. $DFTX thenew.money/article/definiu…
Definium Therapeutics Raises Mega Funding Round To Advance LSD Drug | The New Money

Definium Therapeutics Raises Mega Funding Round To Advance LSD Drug | The New Money

Definium Therapeutics (NASDAQ: DFTX) has successfully raised $805 million in a new equity financing round at a price of $34.00 per share.

thenew.money
1
9
796
Psychedelic Finance retweeted
The Tape (@TheTape_TNM) profile picture
The Tape
@TheTape_TNMJun 22
Breaking: $CMND completes treatment of all 24 participants across four cohorts in Part A of its FDA-regulated Phase I/II CMND-100 trial for alcohol use disorder and will review the data before advancing to the next stage.
1
6
529
Psychedelic Finance retweeted
The New Money (@thenewmoney) profile picture
The New Money
@thenewmoneyJun 11
A publicly traded company on the Nasdaq is shipping psilocybin to the United Kingdom. But, why? $OPTH thenew.money/article/optimi-…
Optimi Health Is Shipping Psilocybin To The UK | The New Money

Optimi Health Is Shipping Psilocybin To The UK | The New Money

Optimi Health (NASDAQ: OPTH) has successfully exported naturally derived psilocybin to the United Kingdom to support a Phase II clinical trial.

thenew.money
1
2
5
380
Psychedelic Finance retweeted
The Tape (@TheTape_TNM) profile picture
The Tape
@TheTape_TNMJun 10
Breaking: $OPTH completes its first export of naturally derived psilocybin to the United Kingdom, supplying biomass and finished 5mg capsules for a planned Phase 2 clinical trial under Health Canada and UK Home Office authorization.
1
1
4
328
Psychedelic Finance retweeted
The Tape (@TheTape_TNM) profile picture
The Tape
@TheTape_TNMJun 1
Breaking: $TELIF signs an agreement to deploy its third Self-Driving Lab platform of fiscal 2026 for a major global pharmaceutical company in Europe.
1
5
418
Psychedelic Finance retweeted
The Tape (@TheTape_TNM) profile picture
The Tape
@TheTape_TNMMay 28
Breaking: $ATAI launches a Patient Impact Grant Program awarding three $20,000 grants to mental health non-profits focused on community support, education, stigma reduction and independent research.
3
10
428
Psychedelic Finance retweeted
The Tape (@TheTape_TNM) profile picture
The Tape
@TheTape_TNMMay 13
Breaking: $CMPS reports Q1 2026 results with cash and cash equivalents of ~$216M, providing runway into 2027 as it advances late-stage COMP360 psilocybin trials toward potential commercialization for treatment-resistant depression.
2
2
11
832
Psychedelic Finance retweeted
The New Money (@thenewmoney) profile picture
The New Money
@thenewmoneyApr 20
Psychedelic medicines are getting a big boost of support from the White House. And it might be just the beginning of reshaping the future of psychedelic drugs in America. thenew.money/article/theres-…
There’s A New Executive Order For Psychedelics In The USA | The New Money

There’s A New Executive Order For Psychedelics In The USA | The New Money

President Donald Trump signed a new executive order known as Accelerating Medical Treatments for Serious Mental Illness focused on using psychedelic medicines.

thenew.money
2
6
15
713
Psychedelic Finance retweeted
The Tape (@TheTape_TNM) profile picture
The Tape
@TheTape_TNMMar 17
Breaking: $ATAI says BPL-003 shows rapid and durable antidepressant effects in treatment-resistant depression, supporting Phase 3 trials set to begin in Q2 2026.
5
2
9
605
Psychedelic Finance retweeted
The New Money (@thenewmoney) profile picture
The New Money
@thenewmoneyFeb 17
Breaking: Compass Pathways has successfully achieved the primary endpoint for their COMP360 drug in their second Phase III trial for treating individuals with treatment resistant depression. $CMPS $ATAI
1
2
16
1,853
Psychedelic Finance retweeted
The Tape (@TheTape_TNM) profile picture
The Tape
@TheTape_TNMFeb 17
Breaking: $CMPS reports its COMP360 psilocybin treatment met the primary endpoint in its second Phase 3 trial for treatment-resistant depression.
3
1
12
1,114
Psychedelic Finance retweeted
The New Money (@thenewmoney) profile picture
The New Money
@thenewmoneyJan 24
Our next newsletter goes out soon. Discover the week's biggest news, top performing companies, and the Trends that moved markets. Join free: thenew.money/join
Join Us | The New Money

Join Us | The New Money

Discover what's next. The markets and trends that matter, made simple.

thenew.money
3
4
591
Psychedelic Finance retweeted
The New Money (@thenewmoney) profile picture
The New Money
@thenewmoneyJan 21
Billionaire @C_Angermayer is one of the world’s most prolific entrepreneurs and investors in technology and biotech. And his psychedelic drug development company is on a mission to change the future of psychedelic medicines in America. $ATAI thenew.money/article/christi…
Christian Angermayer’s AtaiBeckley Is All In On Psychedelic Medicines In America | The New Money

Christian Angermayer’s AtaiBeckley Is All In On Psychedelic Medicines In America | The New Money

Psychedelic drug development company AtaiBeckley (NASDAQ: ATAI) has officially completed their redomiciliation into the United States of America.

thenew.money
2
15
1,132
Load more